GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Quick Ratio

Beijing Konruns Pharmaceutical Co (SHSE:603590) Quick Ratio : 3.59 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Beijing Konruns Pharmaceutical Co's quick ratio for the quarter that ended in Mar. 2025 was 3.59.

Beijing Konruns Pharmaceutical Co has a quick ratio of 3.59. It generally indicates good short-term financial strength.

The historical rank and industry rank for Beijing Konruns Pharmaceutical Co's Quick Ratio or its related term are showing as below:

SHSE:603590' s Quick Ratio Range Over the Past 10 Years
Min: 2.49   Med: 4.95   Max: 10.75
Current: 3.59

During the past 12 years, Beijing Konruns Pharmaceutical Co's highest Quick Ratio was 10.75. The lowest was 2.49. And the median was 4.95.

SHSE:603590's Quick Ratio is ranked better than
51.62% of 1478 companies
in the Biotechnology industry
Industry Median: 3.4 vs SHSE:603590: 3.59

Beijing Konruns Pharmaceutical Co Quick Ratio Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Quick Ratio Chart

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.98 5.82 5.68 3.65 2.88

Beijing Konruns Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.08 2.93 3.36 2.88 3.59

Competitive Comparison of Beijing Konruns Pharmaceutical Co's Quick Ratio

For the Biotechnology subindustry, Beijing Konruns Pharmaceutical Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Konruns Pharmaceutical Co's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Konruns Pharmaceutical Co's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Konruns Pharmaceutical Co's Quick Ratio falls into.


;
;

Beijing Konruns Pharmaceutical Co Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Beijing Konruns Pharmaceutical Co's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Quick Ratio (A: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1086.54-72.383)/352.683
=2.88

Beijing Konruns Pharmaceutical Co's Quick Ratio for the quarter that ended in Mar. 2025 is calculated as

Quick Ratio (Q: Mar. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1192.375-69.87)/312.765
=3.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Konruns Pharmaceutical Co  (SHSE:603590) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Beijing Konruns Pharmaceutical Co Quick Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Konruns Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.
Executives
Feng Zhang Zheng Director

Beijing Konruns Pharmaceutical Co Headlines

No Headlines